Regulatory
The Trump administration finalized a rule barring United States — Medicaid and the United States — Children s Health Insurance Program (CHIP) from funding puberty blockers, hormone therapy, and surgeries for gender dysphoria in minors.…
Impact: The AMA supports access to gender-affirming care and opposes the restriction, aligning with its stance that such decisions should be made by patients, families, and clinicians. The association's position may influence public opinion and legal arguments.
Aug 11, 2026 · 39 articles